BioCentury
ARTICLE | Company News

Enkam, CHDI Inc. deal

December 11, 2006 8:00 AM UTC

CHDI, a not-for-profit organization focused on Huntington's disease (HD), will provide Enkam with an undisclosed amount of funding for preclinical development of two of the company's compounds targeti...